Stock Events

Stock Events

Nevro 

$5.84
12
+$0+0% Wednesday 19:59

Statistics

Day High
5.86
Day Low
5.84
52W High
13.3
52W Low
3.17
Volume
751,504
Avg. Volume
1,300,285
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30AprExpected
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.41
-1.02
-0.64
-0.25
Expected EPS
-0.846466
Actual EPS
N/A

Financials

-27.77%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
408.52MRevenue
-113.44MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NVRO. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.33B
Medtronic is a leading competitor in the neuromodulation market, offering spinal cord stimulation devices that compete directly with Nevro's Senza system for chronic pain management.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories competes in the chronic pain management space with its portfolio of neuromodulation products, including spinal cord stimulation devices that rival Nevro's offerings.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific is a key player in the neuromodulation sector, providing spinal cord stimulators that directly compete with Nevro's products for the treatment of chronic pain.
Smith & Nephew
SNN
Mkt Cap15.61B
Smith & Nephew operates in the medical technology field, offering products that, while more focused on orthopedics, include treatments that can compete with Nevro's pain management solutions.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. competes with Nevro through its diverse range of medical devices, some of which are used in pain management and can be seen as alternatives to spinal cord stimulation.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation offers medical devices and equipment that, while broader in scope, include neuromodulation and pain management solutions that can compete with Nevro's offerings.
Globus Medical
GMED
Mkt Cap8.16B
Globus Medical, Inc. focuses on musculoskeletal solutions, including devices for pain management that can compete with Nevro's spinal cord stimulation devices in certain applications.
Edwards Lifesciences
EW
Mkt Cap48.41B
Edwards Lifesciences Corporation, primarily known for heart valves, also ventures into areas that can indirectly compete with Nevro's pain management solutions through their patient care innovations.
Integra Lifesciences
IART
Mkt Cap935.48M
Integra LifeSciences Holdings Corporation offers products in neurosurgery and other medical device categories that, while not directly competing, offer alternative solutions to pain management, potentially competing with Nevro's market.

About

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
Show more...
CEO
Mr. Kevin R. Thornal
Employees
1099
Country
US
ISIN
US64157F1030

Listings

0 Comments

Share your thoughts

FAQ

What is Nevro stock price today?▼
The current price of NVRO is $5.84 USD — it has increased by +0% in the past 24 hours. Watch Nevro stock price performance more closely on the chart.
What is Nevro stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Nevro stocks are traded under the ticker NVRO.
Is Nevro stock price growing?▼
NVRO stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Nevro has showed a +0% increase.
What is Nevro revenue for the last year?▼
Nevro revenue for the last year amounts to 408.52M USD.
What is Nevro net income for the last year?▼
NVRO net income for the last year is -113.44M USD.
How many employees does Nevro have?▼
As of April 03, 2026, the company has 1,099 employees.
In which sector is Nevro located?▼
Nevro operates in the Health Care sector.
When did Nevro complete a stock split?▼
Nevro has not had any recent stock splits.
Where is Nevro headquartered?▼
Nevro is headquartered in Redwood City, US.